Welcome to the May Edition of our Newsletter!
MOLDEV_LOGO_RBG_ADVANCING_DISCOVERY-1

May 2023 Newsletter

View in browser
MicrosoftTeams-image (18) copy 2-1

Welcome to the May edition of our newsletter!

For 40 years, we’ve helped scientists harness the full potential of biology with next-generation technology. Here we share the latest in automated, end-to-end solutions that span research disciplines to advance scientific discovery and improve the quality of human life worldwide.

divider
DDPIpage0001

The Revolutionary Promise of Organoids

NEW Interactive Infographic

 

In the midst of an evolving drug discovery paradigm, researchers worldwide are transitioning their compound screens away from 2D cell cultures and animal models to more complex, human-relevant 3D systems like organoids. For our latest blog post, we developed an interactive web experience that takes you deeper into why the industry is embracing this next generation of drug discovery and the innovations supporting scientists in their 3D biology journey.

 

This dynamic new interactive experience includes real-world applications and research to show you what’s possible with 3D biology. In addition, it answers common questions associated with next-generation drug discovery.

MD-IMG-MOV-Drug_Discovery_Paradigm_Ceros_Preview_AdobeExpress(1)
Explore the Infographic
divider
Banner_LabNotes_ELISA

ELISA applications in Drug Discovery and Development

Ready to unlock the full potential of ELISA?

 

This new Lab Notes blog covers how our experts use ELISA assays in their research, the specific benefits of this kind of immunoassay, what research directions have been opened up through the use of ELISA, and much more. 

 

Tune in to listen as Dr. Ana Miletic, senior research scientist at Kyowa Kirin, Anna Dey, MSc in Biotechnology at John Hopkins University, and Dr. Cathy Olsen, senior application scientist at Molecular Devices discuss what makes the ELISA stand out and how it can be adapted to the rapidly evolving drug discovery scene.

 

Key learning points:

  • ELISA applications in drug discovery and development
  • Advantages of ELISA applications compared to other immunoassays
  • ELISA instrumentation and automation workflow solutions
  • What the Future Holds for ELISA
Explore ELISA Advantages
divider
Banners-email-QPix XE launch-01-1-1

Streamline your Colony Selection and Picking with QPix XE

Accuracy, precision, and quality – all in a smaller package.

 

As a leader in research, you're always looking for ways to streamline your processes to make new discoveries. So why not choose the smarter solution that takes colony picking technology to the next level? Introducing the all-new QPix XE Microbial Colony Picker – the solution to your colony selection and picking needs.

 

Ideal for small lab spaces with no compromise on efficiency, with advanced imagining and robotic capabilities, the QPix XE allows for further integration into an automated work cell for throughput growth or walkaway time.

    Learn More about QPix XE
    divider
    Banner-email-Scaling up organoids podcast-20230417

    The Final Episode of our Organoids Mini Series is now live!

    Tune in to hear experts discussing scaling up 3D organoids

     

    Over the past few months, we’ve been producing a series of podcasts on organoids – speaking to some leading figures in this exciting research area. The fourth (and final) episode in this mini-series has just been released by Drug Target Review, focusing on scaling up organoid research.

     

    This is a critically important topic, as by scaling up across the workflow – from obtaining the large quantities of reproducible, consistent organoids needed for a robust screening program, to quickly getting actionable, reliable data  to take their next step with confidence– scientists can fully access the potential of these powerful 3D models.

      Tune into the Podcast
      divider
      Banner-email-FLIPR flyer-20230421

      Applications and Anatomy of FLIPR Penta

      New Interactive Flyer 

       

      Are you aware of what FLIPR Penta is capable of? Check out all the assays FLIPR Penta can do in the new interactive flyer, and click on each assay to find an application note for it. We also included a diagram that explains the anatomy of this industry-renowned high-throughput cellular screening system.

       

      FLIPR can perform a vast range of assays, including GPCR, membrane potential, cardiomyocytes, potassium channels, ligand-gated calcium channels, 3D assays, and biochemical assays, using kits available on the website. Download the flyer to learn the details.

       

      Download Now
      divider
      Email Banner

      NEW: DispenCell & CloneSelect Imager FL Bundle

      Find out how much you can save today!

       

      Ready to redefine the possibilities of single-cell analysis? Introducing the ultimate duo for workflow optimization: the all-new DispenCell Single-Cell Dispenser and CloneSelect Imager FL Bundle.

       

      Get started today by taking advantage of this limited-time special bundle.

        Learn More
        divider
        Banner-email-app 2500A_Kinetic-QCL-20220621 (2)

        Application Spotlight 

        Quantify TNFa secretion by THP-1-derived macrophages with an AlphaLISA assay

         

        A major cellular component of the tumor microenvironment, tumor-associated macrophages are often associated with poor prognosis and are under investigation as potential targets for anticancer therapy.

         

        In this application note, effects of several anti-inflammatory compounds on TNFα secretion by THP-1-derived macrophages were measured using the AlphaLISA High Performance (HP) Human Tumor Necrosis Factor alpha (TNFα) Detection Kit. Using the SpectraMax i3x Multi-Mode Microplate Reader and this homogeneous assay, picogram levels of TNFα were detected in culture medium removed from THP-1 cells activated with PMA and LPS, and further treated with the compounds SB202190, stattic, and resveratrol.

          Read the Application Note
          divider

          EVENTS

           

          3D Tissue Models Summit 

          May 16-18, 2023 | Boston, MA 

           

          The American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting 

          May 16-20, 2023 | Los Angeles, CA

           

          SynBioBeta 

          May 23-25, 2023 | Oakland, CA

           

          SLAS Europe 

          May 22-May 26, 2023 | Brussels, Belgium 

          divider

          JOIN OUR TEAM

          Ready to reach your full potential? Click here to see what life is like at Molecular Devices.

          Facebook
          LinkedIn
          Twitter
          YouTube

          Privacy Policy | Terms & Conditions | Trademarks & Logos

           

          For Research Use Only. Not for use in diagnostic procedures.

          The trademarks mentioned herein are the property of Molecular Devices, LLC or their respective owners. ©2023 Molecular Devices, LLC 3860 N First Street, San Jose, CA, 95134 USA

           

          View email in browser, update your email preferences or unsubscribe.

           

           

          Please be advised that this email may contain confidential information. If you are not the intended recipient, please notify us by email by replying to the sender and delete this message. The sender disclaims that the content of this email constitutes an offer to enter into, or the acceptance of, any agreement; provided that the foregoing does not invalidate the binding effect of any digital or other electronic reproduction of a manual signature that is included in any attachment.